Clinical features compatible with MPA diagnosis develop in up to 25% MPO-ANCA-positive patients whose ILD was initially classified as idiopathic pulmonary fibrosis (IPF) [[17], [18], [19], [20]]. This evidence concerns the gene MPO and idiopathic pulmonary fibrosis.